Document is current
Any future updates will be listed below
-
Authors
Minnerath, Elizabeth https://orcid.org/0009-0001-3219-2225
Khazen, Olga https://orcid.org/0000-0001-6177-7604
Panicker, Jalesh N. https://orcid.org/0000-0001-5190-3259
Drake, Marcus J. https://orcid.org/0000-0002-6230-2552
De, Elise J. B. https://orcid.org/0000-0003-0730-9038
-
Funding
Funding for this research was provided by:
United Kingdom’s Department of Health NIHR University College London Hospitals Biomedical Research Centres funding scheme
- License Information
-
More Information
Article History
Received: 31 March 2026
Accepted: 14 May 2026
First Online: 2 June 2026
Declarations
: JNP is supported in part by funding from the United Kingdom’s Department of Health NIHR University College London Hospitals Biomedical Research Centres funding scheme.
: MD is on speaker bureau and advisory boards for Astellas, Pierre Fabre, Nowwell, and Viatris.
: ED is Chair DSMB NIDDK/NIH Protocol Number: EPPIC22001, a consultant for Flume catheters and Luca Biologics, is on the advisory board for Ironwood Pharmaceuticals and Glycologix, was PI on a study for Ironwood pharmaceuticals, has stock in Doximity and ERYP, Shares in Restoration Medicine, Owner of Pelvic Answers LLC and runs .
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.
